BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. - Petrelli A; Rizzolio S; Pietrantonio F; Bellomo SE; Benelli M; De Cecco L; Romagnoli D; Berrino E; Orrù C; Ribisi S; Moya-Rull D; Migliore C; et al. (Cancer research, 2023)